Saturday, December 22, 2018

Revmoksikam

Description overdue on 08.11.2011

Related Articles:
  • Gepabene, reviews about the drug
  • Contraindications Qudesan
  • Instructions for use Atrovent inhalation
  • Buy Ferezol in St. Petersburg
Tweet

 Revmoksikam  The main active ingredient is the current meloxicam . It has antipyretic, analgesic, anti-inflammatory action. The principle of operation is to reduce the meloxicam formulation and synthesis prostaglandins   (are inflammatory mediators). Produced in tablet form, as a solution for injection (1% to 1, 5 mL), suppositories.

Indications:

Revmoksikam prescribed for degenerative, inflammatory diseases of the joints: osteoarthritis . aptroz . ankylosing spondylitis . Rheumatoid arthritis .

Contraindications:

Revmoksikam not used for ulcerative lesions of the gastrointestinal tract, disorders of the renal and hepatic systems during pregnancy and allergy to NSAIDs.

Side effect:

Gastrointestinal tract : Marked dyspepsia, epigastric pain, stomatitis . esophagitis , Intestinal colic, disorders of the chair. Rarely develop ulcerative lesions of the gastrointestinal tract. Nervous system : Sleep disorder, tinnitus, dizziness, irritability , Lability of mood, disorientation. Cardiovascular system : Swelling, heart palpitations, increased blood pressure, flushing. The urinary system : Increase in urea creatinine , Renal medullary necrosis glomerulonephritis , Nephrotic syndrome. Forming Organs : Thrombocytopenia, anemia, decreased hemoglobin, hematocrit. Blurred vision, allergic conjunctivitis, erythema multiforme , Bullous reaction, photosensitivity.


Mode of application:

Revmoksikam taken 1 time a day during meals. Ankylosing spondylitis Rheumatoid arthritis: 15 mg per day. After achieving the desired therapeutic effect, reduce dosage Revmoksikama to 7, 5 mg. Osteoarthritis : Day - 7, 5 mg (may be increased up to 15 mg). Suppositories 1 day candle. We do not recommend the use of suppositories more than 7 days. After a five-day course necessary to switch to tablet form of the drug. Injections : Revmoksikam injected deep intramuscularly (7, 5-15 mg). The course of injections is 3-5 days, after which you need to move on to oral drug tablets.

Overdose:

It is noted increased side effects. Requires the introduction of adsorbents, gastric lavage. No antidote.

Special instructions:

Revmoksikam prescribed with caution in patients with cirrhosis of the liver , Asthma, gastrointestinal diseases, congestive heart failure. Patients receiving anticoagulants and antiplatelet agents, is not recommended to make their own Revmoksikam. In diseases of the renal system requires regular monitoring of renal. Revmoksikam reduces the speed of psychomotor reactions. Does driving a vehicle.

Drug Interactions:

When receiving Revmoksikama amplifies the effect of indirect anticoagulants. Parenteral administration ticlopidine   and Heparin   increases the risk of gastrointestinal bleeding, ulcerogenic effects. Revmoksikam reduces excretion lithium kidneys, which leads to the accumulation of lithium in the body to toxic doses. The drug reduces the protective effect of the contraceptive intrauterine device. Methotrexate   can cause pancytopenia (depletion of bone marrow). Kolestiramin   meloxicam increases the excretion from the body. The action of ACE inhibitors, beta-blockers under the influence of the drug Revmoksikam greatly reduced.

No comments:

Post a Comment